Ngā hua rapu - Cavazos, David
- E whakaatu ana i te 1 - 12 hua o te 12
-
1
Modulation of Telomeres in Alternative Lengthening of Telomeres Type I Like Human Cells by the Expression of Werner Protein and Telomerase mā Siddiqa, Aisha, Cavazos, David, Chavez, Jeffery, Long, Linda, Marciniak, Robert A.
I whakaputaina 2012Text -
2
-
3
-
4
Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression mā Bowers, Laura W, Cavazos, David A, Maximo, Ilane XF, Brenner, Andrew J, Hursting, Stephen D, deGraffenried, Linda A
I whakaputaina 2013Text -
5
-
6
MNGI-11. TREATMENT OF MENINGIOMA WITH TH-302 IN A PDX MOUSE MODEL AND CELL LINE mā Patel, Vaibhav, Maknojia, Asif, Garcia, Michael, Cavazos, David, Gruslova, Aleksandra, Courtney, Bosse, Papanikolaou, Niko, Kidane, Dawit, Brenner, Andrew, Floyd, John
I whakaputaina 2017Text -
7
DD-02 PHARMACODYNAMIC BIOMARKER ASSESSMENTS IN A PHASE I/II TRIAL OF THE HYPOXIA-ACTIVATED PRODRUG TH-302 AND BEVACIZUMAB IN BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA mā Cavazos, David, Gruslova, Aleksandra, Sun, J., Floyd, John R., Fichtel, Lisa, Tadi, Surendar, Lodi, Alessia, Tiziani, Stefano, Hart, C.P., Eng, Clarence, Brenner, Andrew
I whakaputaina 2014Text -
8
VB-111: A novel anti-vascular therapeutic for glioblastoma multiforme mā Gruslova, Aleksandra, Cavazos, David A, Miller, Jessica R., Breitbart, Eyal, Cohen, Yael C, Bangio, Livnat, Yakov, Niva, Soundararajan, Anu, Floyd, John R., Brenner, Andrew J.
I whakaputaina 2015Text -
9
Hypoxia-activated evofosfamide for treatment of recurrent bevacizumab-refractory glioblastoma: a phase I surgical study mā Brenner, Andrew, Zuniga, Richard, Sun, Jessica D, Floyd, John, Hart, Charles P, Kroll, Stew, Fichtel, Lisa, Cavazos, David, Caflisch, Laura, Gruslova, Aleksandra, Huang, Shiliang, Liu, Yichu, Lodi, Alessia, Tiziani, Stefano
I whakaputaina 2018Text -
10
Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma mā Sareddy, Gangadhara R., Li, Xiaonan, Liu, Jinyou, Viswanadhapalli, Suryavathi, Garcia, Lauren, Gruslova, Aleksandra, Cavazos, David, Garcia, Mike, Strom, Anders M., Gustafsson, Jan-Ake, Tekmal, Rajeshwar Rao, Brenner, Andrew, Vadlamudi, Ratna K.
I whakaputaina 2016Text -
11
5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cells() mā Henry, Sean, Kidner, Ria, Reisenauer, Mary R., Magedov, Igor V., Kiss, Robert, Mathieu, Véronique, Lefranc, Florence, Dasari, Ramesh, Evidente, Antonio, Yu, Xiaojie, Ma, Xiuye, Pertsemlidis, Alexander, Cencic, Regina, Pelletier, Jerry, Cavazos, David A., Brenner, Andrew J., Aksenov, Alexander V., Rogelj, Snezna, Kornienko, Alexander, Frolova, Liliya V.
I whakaputaina 2016Text -
12
Activity of 2-Aryl-2-(3-indolyl)acetohydroxamates Against Drug-Resistant Cancer Cells mā Aksenov, Alexander V., Smirnov, Alexander N., Magedov, Igor V., Reisenauer, Mary R., Aksenov, Nicolai A., Aksenova, Inna V., Pendleton, Alexander L., Nguyen, Gina, Johnston, Robert K., Rubin, Michael, De Carvalho, Annelise, Kiss, Robert, Mathieu, Véronique, Lefranc, Florence, Correa, Jaime, Cavazos, David A., Brenner, Andrew J., Bryan, Brad A., Rogelj, Snezna, Kornienko, Alexander, Frolova, Liliya V.
I whakaputaina 2015Text